Surges in flu, RSV and COVID threaten the holidays
Dr. Preeti Malani of the University of Michigan speaks to NPR about the surge of seasonal respiratory viruses, COVID and flu during the holidays.
Health & Safety
Is lecanemab the Alzheimer's drug that will finally make a difference?
The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.
CDC Director Rochelle Walensky advises on the 'tripledemic'
NPR's Ailsa Chang speaks with Center for Disease Prevention and Control Director Rochelle Walensky about the "tripledemic."
Safety advocates detail safety measures as traffic fatalities reach a 16-year high
With traffic fatalities at a 16-year high, safety advocates released an annual report detailing 16 safety measures they say could reduce crashes. They also push for better safety laws.
Juul settles more than 5,000 lawsuits over its vaping products
Juul Labs has reached settlements covering cases brought by about 10,000 plaintiffs related to its vaping products. Buffeted by lawsuits, Juul announced hundreds of layoffs last month.
China announces a rollback of its strict anti-COVID-19 measures
China has announced a series of measures rolling back some of its restrictive anti-COVID-19 restrictions, including limiting the scale of lockdown to individual apartment floors and buildings.
Factory workers across the U.S. say they were exposed to asbestos on the job
Their accounts contrast sharply with what chemical giants have said about worker safety at their facilities. At an Olin plant outside of McIntosh, Ala., workers recall decades of asbestos exposure.
Limited nursing home beds force hospitals to keep patients longer
The lack of nursing home beds means that U.S. hospitals are caring for patients who don't need to be hospitalized but have nowhere else to go.
How China's COVID policy rollbacks will affect the country and the world
With Chinese leaders expected to further loosen the country's notoriously strict COVID policies, how could a rise in cases affect Chinese citizens and the global economy?